Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant adeno-associated viral vectors for treating Bietti Crystalline Dystrophy

Recombinant adeno-associated viral vectors for treating Bietti Crystalline Dystrophy

US Patent 12371474 · Granted Jul 29, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

AAV capsids for targeting nervous system and uses thereof2025
AAV capsids for targeting nervous system and uses thereof2025
AAV capsids for targeting nervous system and uses thereof2025
Hepatitis B antiviral agents2025
Recombinant AAV vectors for treating glutaric aciduria type I2025
Spiropyrrolidine derived antiviral agents2025
Manufacture of compounds and compositions for inhibiting the activity of SHP22025
Memory device and its operating method, memory system and operating method there2025
System and method for debugging Wi-Fi service flow problems2025
Macrocyclic spiropyrrolidine derived antiviral agents2025
Metabolically stable pyrimidinyl dihydroquinoxalinones as tubulin polymerization2025
Biodegradable ultra-pH sensitive polymers2025